Zobrazeno 1 - 10
of 465
pro vyhledávání: '"John W. Funder"'
Autor:
Tram B. Doan, Vanessa Cheung, Colin D. Clyne, Heidi N. Hilton, Natalie Eriksson, Morag J. Young, John W. Funder, George E. O. Muscat, Peter J. Fuller, Christine L. Clarke, J. Dinny Graham
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-16 (2020)
Abstract Background The role of nuclear receptors in both the aetiology and treatment of breast cancer is exemplified by the use of the oestrogen receptor (ER) as a prognostic marker and treatment target. Treatments targeting the oestrogen signalling
Externí odkaz:
https://doaj.org/article/d75a54fc0c0d4205964f8c51ddcf97ff
Autor:
John W. Funder
Publikováno v:
F1000Research, Vol 6 (2017)
Spironolactone has been marketed for over half a century as a ‘potassium-sparing diuretic’, used primarily in patients with ascites. With the realization that primary aldosteronism is the most common (5-13%) form of secondary hypertension, it has
Externí odkaz:
https://doaj.org/article/e81eebbeb7644d0098c38b1713edcac4
Autor:
John W. Funder, Robert M. Carey
Publikováno v:
Hypertension. 79:726-735
Primary aldosteronism, the most common secondary form of hypertension, is thought to be present in ≈5% to 10% of hypertensive adults. However, recent studies indicate that its prevalence may be at least 3-fold higher based on the identification of
Autor:
John W. Funder, Colin Clyne, Morag J Young, Vanessa Cheung, Tram B. Doan, Peter J. Fuller, J. Dinny Graham, Christine L. Clarke, George E.O. Muscat, Heidi N. Hilton, Natalie A. Eriksson
Publikováno v:
Breast Cancer Research, Vol 22, Iss 1, Pp 1-16 (2020)
Breast Cancer Research : BCR
Breast Cancer Research : BCR
Background The role of nuclear receptors in both the aetiology and treatment of breast cancer is exemplified by the use of the oestrogen receptor (ER) as a prognostic marker and treatment target. Treatments targeting the oestrogen signalling pathway
Autor:
John W Funder
Publikováno v:
Am J Hypertens
BACKGROUND: Normal-appearing adrenal glands on cross-sectional imaging may still be the source of aldosterone production in primary aldosteronism (PA). METHODS: We evaluated the prevalence of aldosterone production among morphologically normal-appear
Autor:
John W. Funder
Publikováno v:
Journal of Hypertension. 38:1937-1939
Autor:
John W. Funder
Publikováno v:
Journal of the American College of Cardiology. 75:1923-1925
The study by Xu et al. ([1][1]) in this issue of the Journal is remarkable in a number of ways. As one of the largest primary health care centers in South West China, the First Affiliated Hospital of Chong Quin Medical University does an annual healt
Autor:
John W. Funder
Publikováno v:
Hypertension. 74:458-466
Autor:
John W. Funder
Publikováno v:
Hypertension
Primary aldosteronism is an underdiagnosed cause of hypertension. Although inadequate screening is one reason for underdiagnosis, another important contributor is that clinicians may inappropriately exclude the diagnosis when screening aldosterone co
Autor:
John W. Funder
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 76(2)